Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
skipper1072's Profile
Displaying 301-350 of 407 result(s).
GNBTQ Generex Biotechnology Corp.
04/10/2020 9:30:57 AM
During a lockdown due to the pandem (2)
GNBTQ Generex Biotechnology Corp.
04/09/2020 8:35:10 AM
Wow. Look at what the Fed is doing (2)
GNBTQ Generex Biotechnology Corp.
04/08/2020 4:21:59 PM
I don't see the term "license fee"
GNBTQ Generex Biotechnology Corp.
04/08/2020 3:00:19 PM
Buildit, et al: After reading the c
GNBTQ Generex Biotechnology Corp.
04/08/2020 2:07:31 PM
Yes, Buildit. Of course, it all dep
GNBTQ Generex Biotechnology Corp.
04/08/2020 1:46:45 PM
Thus the invoice.
GNBTQ Generex Biotechnology Corp.
04/08/2020 1:34:32 PM
My guess is the $1 million's been p
GNBTQ Generex Biotechnology Corp.
04/08/2020 11:59:04 AM
Great questions. Even though he isn
GNBTQ Generex Biotechnology Corp.
04/07/2020 9:43:32 AM
We're dealing with huge bureaucraci (2)
GNBTQ Generex Biotechnology Corp.
04/01/2020 4:50:01 PM
I haven't been happy with Epivax fr (1)
GNBTQ Generex Biotechnology Corp.
03/26/2020 1:49:35 PM
Source tells me this is the lobby o (1)
GNBTQ Generex Biotechnology Corp.
03/22/2020 12:18:12 PM
Skipper is ready for any day, 1200
GNBTQ Generex Biotechnology Corp.
03/20/2020 3:44:41 PM
Ye of little faith. I'm hoping for
GNBTQ Generex Biotechnology Corp.
03/20/2020 3:17:35 PM
Vaccine/test revenues will show nex (1)
GNBTQ Generex Biotechnology Corp.
03/19/2020 10:06:27 PM
docj - you summed it up nicely. We (2)
GNBTQ Generex Biotechnology Corp.
03/19/2020 4:11:35 PM
We're in for stunningly large numbe
GNBTQ Generex Biotechnology Corp.
03/19/2020 10:39:56 AM
As usual, RJS focused on the real n (1)
GNBTQ Generex Biotechnology Corp.
03/18/2020 9:34:04 AM
Wonderful podcast performance by Jo
GNBTQ Generex Biotechnology Corp.
03/11/2020 1:59:46 PM
I'm still buying, accumulating. The (6)
GNBTQ Generex Biotechnology Corp.
03/10/2020 4:12:11 PM
EVH's explanations are too scientif (1)
GNBTQ Generex Biotechnology Corp.
03/06/2020 8:58:57 PM
1500 tests conducted in US so far.
GNBTQ Generex Biotechnology Corp.
03/04/2020 7:40:43 PM
Research doesn't generate immediate
GNBTQ Generex Biotechnology Corp.
03/04/2020 6:57:11 PM
It's hard to do the research withou
GNBTQ Generex Biotechnology Corp.
03/04/2020 2:14:59 PM
Good to know. Joe should bring DeGr (1)
GNBTQ Generex Biotechnology Corp.
03/04/2020 1:52:13 PM
Article from All Aboard: "The advan
GNBTQ Generex Biotechnology Corp.
03/04/2020 1:44:52 PM
This is the first I've heard this:
GNBTQ Generex Biotechnology Corp.
03/04/2020 1:00:58 PM
I see this as a wonderful buying op (3)
GNBTQ Generex Biotechnology Corp.
03/04/2020 10:07:58 AM
Unless EpiVax accelerates that proc (1)
GNBTQ Generex Biotechnology Corp.
03/02/2020 10:00:37 AM
No. I received that from Joe. (2)
GNBTQ Generex Biotechnology Corp.
03/02/2020 2:47:58 AM
Joe and team are flying to China to (3)
GNBTQ Generex Biotechnology Corp.
02/29/2020 8:10:03 PM
Is our vaccine RNA-based?
GNBTQ Generex Biotechnology Corp.
02/28/2020 9:58:45 AM
Big money will be in our testing ki
GNBTQ Generex Biotechnology Corp.
02/27/2020 8:12:23 PM
Nice post, Doc. You should work for (1)
GNBTQ Generex Biotechnology Corp.
02/27/2020 6:24:09 PM
It will have to push the timeline f
GNBTQ Generex Biotechnology Corp.
02/27/2020 9:55:59 AM
I keep in mind the fact that years
GNBTQ Generex Biotechnology Corp.
02/27/2020 9:18:53 AM
After 45 minuets with Fidelity, her
GNBTQ Generex Biotechnology Corp.
02/26/2020 9:46:19 PM
Thank you. You saved me another cal
GNBTQ Generex Biotechnology Corp.
02/26/2020 9:22:18 PM
Paul - I'll let you know what my Fi (1)
GNBTQ Generex Biotechnology Corp.
02/26/2020 10:28:39 AM
TC - likewise for me since I bought
GNBTQ Generex Biotechnology Corp.
02/19/2020 8:02:08 AM
1100
GNBTQ Generex Biotechnology Corp.
01/30/2020 9:59:21 AM
I'm not a fan of Dr. Craig Eagle. H (1)
GNBTQ Generex Biotechnology Corp.
12/23/2019 7:48:03 PM
On the positive side, the reduction
GNBTQ Generex Biotechnology Corp.
12/16/2019 8:12:25 PM
10Q - I didn't see one positive in (2)
GNBTQ Generex Biotechnology Corp.
11/29/2019 10:57:24 AM
Uplisting to NAZ when we file S1 an (1)
GNBTQ Generex Biotechnology Corp.
11/29/2019 10:09:04 AM
S1 filing = $40 million
GNBTQ Generex Biotechnology Corp.
11/26/2019 3:35:57 PM
Now is the time for a class action
GNBTQ Generex Biotechnology Corp.
11/24/2019 10:52:21 AM
Docj - I've been around a long time
GNBTQ Generex Biotechnology Corp.
11/14/2019 8:42:39 AM
#8506, then #8530 would infer that.
GNBTQ Generex Biotechnology Corp.
11/14/2019 8:35:23 AM
Respectfully docj, there are no win
GNBTQ Generex Biotechnology Corp.
11/12/2019 12:11:17 PM
I'm impressed with the pps stabilit (1)
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Exciting Developments: Vaultro Finance to Launch Unique Dashboard
  • Altura Energy Secures Funding Through Private Placement Offering
  • TruGolf Links Welcomes New Franchisee for Growth on Long Island
  • Innovative Partnership: Cannabix's BreathLogix Alcohol Testing Device
  • Exploring the Future of AR with Himax and Vuzix Partnership
  • Neuronetics Celebrates First National TMS Therapy Awareness Day
  • Transforming Coffee Retail: Reborn Coffee Partners with Tori AI
  • Join Onfolio Holdings for Insights at the Upcoming Conference
  • Enhancing Urban Transit Safety with Foresight's 3D Technology
  • Hyland Appoints John Newton as Chief Innovation Strategist
  • Revolutionizing Data Privacy with Foxit's AI Redaction Platform
  • Silo Pharma’s Groundbreaking SPC-15 Study Marks New Chapter
  • Theriva Biologics Showcases 2025 Q1 Successes and Insights
  • Workday CFO Zane Rowe to Share Insights at Upcoming Conference
  • Investing in America's Future: The Call for Infrastructure Action
  • Transforming Food Intelligence with AI Capabilities from Datassential
  • Dream Exchange Applauds Dr. Ioannis Floros for Academic Achievement
  • Celebrating National Public Works Week: A Commitment to Community
  • Exciting Growth Strategies Unveiled by Galloway & Company, LLC
  • Revolutionizing Real Estate with A.I.: Meet the Future Now
  • Celebrating Leadership Excellence: Noble Business Awards Revealed
  • Telehealth Trends: Overweight and Obesity Rise in Demand
  • Explore BOYA's BOYAMIC 2 and BOYALINK 3 Audio Innovations
  • Celebrating Five Decades of Craftsmanship at Adeler Jewelers
  • Empowering Growth: SixFour3's Expansion and New Facilities
  • Matt Dunie Enhances Leadership at CEO Coaching International
  • Engaging Insights from Kay Properties' Annual Investor Day 2025
  • Prescient Healthcare Group Achieves B Corp Certification
  • Secafy Integrates Menta's eFPGA for Enhanced Semiconductor Security
  • Advanced Technology Services Achieves Best Managed Status Again
  • American Rebel Light Beer Sponsors Exciting Concert Series
  • SAIHEAT’s Groundbreaking Patent for Small Modular Reactor Control
  • Ernexa Therapeutics Launches Texas Subsidiary to Accelerate ERNA-101
  • Ethical Web AI Launches AI Vault on AWS Marketplace for Enterprises
  • FDCTech's Remarkable Q1 2025 Growth and Future Prospects
  • LPL Financial Unveils Innovative Alternatives Education Hub
  • iPower's New Initiative: Boosting Domestic Manufacturing Success
  • CleanCore Solutions Surges with 77.7% Revenue Growth This Quarter
  • Blüm Holdings Inc. Shows Significant Growth in Q1 2025 Results
  • Impressive Growth in NETSOL Technologies' Q3 Performance
  • Brag House Firmly Investigates Potential Illegal Short Selling
  • Robex's Kiniero Gold Project Nears Completion Ahead of Schedule
  • Join Inuvo, Inc. at the Upcoming Innovation Expo Event
  • Surrozen's Latest Patent Marks Milestone in Wnt Pathway Therapy
  • Star Equity Holdings, Inc. Q1 2025 Financial Analysis
  • ArcelorMittal Updates on Designated Person Notifications
  • RIAS A/S Shares Insights from Recent Half-Year Performance
  • Landsbankinn's Successful Covered Bond Exchange Results Explained
  • Innovative Partnership to Revolutionize Programmatic Audio Ads
  • Empowering Latinas: Highlights from the 22nd Annual Symposium
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site